American Association for Cancer Research

SHERPA: Unknown

People

  1. Schultz
    Schultz
  2. De Stanchina
    De Stanchina
  3. Berger
    Berger
  4. Rudin
    Rudin
  5. Solit
    Solit
  6. Ladanyi
    Ladanyi
  7. Weigelt
    Weigelt
  8. Arcila
    Arcila
  9. Budhu
    Budhu
  10. Chandarlapaty
    Chandarlapaty

Groups

  1. Department of Medicine (172)
  2. GSK Faculty (149)
  3. Solid Tumor Oncology Division (145)
  4. Sloan Kettering Institute Postdocs (117)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (84)
  6. Human Oncology and Pathogenesis Program (68)
  7. Department of Pathology and Laboratory Medicine (63)
  8. Hematology-Oncology Fellows (61)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (58)
  10. Epidemiology and Biostatistics (52)
Search Within
  1. "2022"
Formats
  1. Meeting Abstract (180)
  2. Journal Article (73)
  3. Editorial (10)
  4. Review (3)
Groups
  1. Department of Medicine (172)
  2. GSK Faculty (149)
  3. Solid Tumor Oncology Division (145)
  4. Sloan Kettering Institute Postdocs (117)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (84)
  6. Human Oncology and Pathogenesis Program (68)

More Groups

People
  1. Nikolaus Schultz (19)
  2. Elisa De Stanchina (17)
  3. Michael Berger (16)
  4. Charles Rudin (15)
  5. David Solit (12)
  6. Dmitriy Zamarin (11)

More People

Years
  1. 2022 (266)
Publications
  1. Cancer Research (191)
  2. Clinical Cancer Research (75)

Results (266)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting non-canonical Hippo pathway in NRF2-mutant liver cancer
    Meeting Abstract

    Sanghvi, V.; Rust, A.; Leibold, J.; Lowe, S.; Viale, A.; Chodera, J.; Hendrickson, R. C.; de Stanchina, E.; Wendel, H. G.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Tepotinib efficacy and safety in patients with MET exon 14 (METex14) skipping NSCLC
    Meeting Abstract

    Garassino, M. C.; Le, X.; Iam, W. T.; Felip, E.; Sakai, H.; Veillon, R.; Smit, E. F.; Mazieres, J.; Raskin, J.; Cortot, A. B.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Environmental factors associated with residual disease after ovarian cancer primary cytoreduction surgery
    Meeting Abstract

    Phung, M. T.; Berchuck, A.; Goode, E. L.; Goodman, M. T.; Hanley, G. E.; Richardson, J.; Grout, B.; Chase, A.; Deurloo, C. M.; Karlan, B. Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Variability in NTRK gene fusions does not appear to impact response to larotrectinib
    Meeting Abstract

    Ladanyi, M.; Roy-Chowdhuri, S.; Ritterhouse, L.; Sahm, F.; Norenberg, R.; Shen, K.; Chen, C.; Fellous, M.; Brega, N.; van Tilburg, C. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The Clinical Genome Resource (ClinGen) somatic cancer clinical domain working group
    Meeting Abstract

    Saliba, J.; Raca, G.; Roy, A.; King, I.; Selvarajah, S.; Xu, X.; Kanagal-Shamanna, R.; Satgunaseelan, L.; Meredith, D.; Evans, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in solid tumors with defects in polymerase epsilon
    Meeting Abstract

    Rousseau, B.; Bieche, I.; Pasmant, E.; Hamzaoui, N.; Leulliot, N.; Michon, L.; de Reynies, A.; Foote, M.; Masliah-Planchon, J.; Svrcek, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 biomarker analyses
    Meeting Abstract

    Lei, M.; Janjigian, Y. Y.; Ajani, J. A.; Moehler, M.; Wang, X.; Shen, L.; Garrido, M.; Gallardo, C.; Yamaguchi, K.; Wyrwicz, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of parsaclisib-ruxolitinib combination therapy in myelofibrosis patients (Pts) with low vs higher baseline platelet count (PC): A subgroup analysis of data from a phase 2 study
    Meeting Abstract

    Yacoub, A.; Borate, U.; Rampal, R.; Ali, H.; Wang, E.; Gerds, A.; Hobbs, G.; Kremyanskaya, M.; Winton, E.; O'Connell, C.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Tools for collecting pathologist annotations and understanding interobserver variability
    Meeting Abstract

    Elfer, K. N.; Blenman, K.; Dudgeon, S. N.; Garcia, V.; Ehinger, A.; Li, X. X.; Ly, A.; Peeters, D.; Werness, B.; Hanna, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • PETRA: First in class, first in human trial of the next generation PARP1-selective inhibitor AZD5305 in patients (pts) with BRCA1/2, PALB2 or RAD51C/D mutations
    Meeting Abstract

    Yap, T. A.; Im, S. A.; Schram, A. M.; Sharp, A.; Balmana, J.; Baird, R. D.; Brown, J. S.; Schwaederle, M.; Pilling, E. A.; Moorthy, G.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: